Zoton



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 50.0%
Anaplastic Large-cell Lymphoma 12.5%
Dyspepsia 12.5%
Iron Deficiency Anaemia 12.5%
Vomiting 12.5%
Cholestasis 16.7%
Off Label Use 16.7%
Ph Urine Increased 16.7%
Product Size Issue 16.7%
Thrombocytopenia 16.7%
White Blood Cell Count Increased 16.7%
Secondary
Prophylaxis 27.4%
Helicobacter Infection 17.3%
Product Used For Unknown Indication 14.3%
Hypertension 6.0%
Epilepsy 5.4%
Staphylococcal Infection 3.6%
Unevaluable Event 3.6%
Asthma 2.4%
Schizophrenia 2.4%
Sedation 2.4%
Stress Ulcer 2.4%
Drug Use For Unknown Indication 1.8%
Gastrooesophageal Reflux Disease 1.8%
Prophylaxis Against Gastrointestinal Ulcer 1.8%
Urinary Tract Infection 1.8%
Atrial Fibrillation 1.2%
Deep Vein Thrombosis 1.2%
Gastroenteritis Viral 1.2%
Gastrointestinal Carcinoma 1.2%
Hyperglycaemia 1.2%
Swollen Tongue 26.5%
Toxic Epidermal Necrolysis 23.5%
Somnolence 11.8%
Insomnia 5.9%
Renal Failure Acute 5.9%
White Blood Cell Disorder 5.9%
Depression 2.9%
Lower Respiratory Tract Infection 2.9%
Mesenteric Artery Thrombosis 2.9%
Rash 2.9%
Sepsis 2.9%
Sinus Tachycardia 2.9%
Uveitis 2.9%
Concomitant
Drug Use For Unknown Indication 35.1%
Product Used For Unknown Indication 12.7%
Rheumatoid Arthritis 12.7%
Hypertension 4.1%
Asthma 3.7%
Prophylaxis 3.5%
Osteoporosis 3.1%
Breast Cancer 2.5%
Diffuse Large B-cell Lymphoma 2.5%
Schizophrenia 2.5%
Insomnia 2.3%
Depression 2.1%
Constipation 2.0%
Her-2 Positive Breast Cancer 2.0%
Analgesic Therapy 1.7%
Gastrooesophageal Reflux Disease 1.7%
Dyspepsia 1.6%
Blood Cholesterol Increased 1.4%
Multiple Myeloma 1.4%
Pain 1.4%
Weight Decreased 12.0%
Pain 8.4%
Death 7.2%
Progressive Multifocal Leukoencephalopathy 7.2%
Vomiting 6.0%
Hyponatraemia 4.8%
Liver Function Test Abnormal 4.8%
Malaise 4.8%
Pyrexia 4.8%
Abdominal Pain Upper 3.6%
Asthma 3.6%
Breast Cancer 3.6%
Cerebrovascular Accident 3.6%
Hallucination 3.6%
Nausea 3.6%
Pneumonia 3.6%
Pulmonary Cavitation 3.6%
Sinusitis 3.6%
Thinking Abnormal 3.6%
Weight Increased 3.6%